WO2026069163 - DIFFERENTIATION METHOD FOR PRODUCING IMMATURE BETA CELLS
National phase entry is expected:
Publication Number
WO/2026/069163
Publication Date
02.04.2026
International Application No.
PCT/IB2025/059623
International Filing Date
24.09.2025
Title **
[English]
DIFFERENTIATION METHOD FOR PRODUCING IMMATURE BETA CELLS
[French]
PROCÉDÉ DE DIFFÉRENCIATION POUR LA PRODUCTION DE CELLULES BÊTA IMMATURES
Applicants **
CRISPR THERAPEUTICS AG
Inventors
LIAO, Meichen
Priority Data
63/699,111
25.09.2024
US
63/776,284
24.03.2025
US
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
EPO
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| Translation |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 6279 | |
| EPO | Filing, Examination, Granting | 127161 | |
| Japan | Filing, Examination, Granting | 4961 | |
| South Korea | Filing, Examination, Granting | 8868 | |
| USA | Filing, Examination, Granting | 27440 |
Total:
174,709
Contact Us
Abstract[English]
Disclosed herein include methods, compositions, and kits suitable for use in cell therapy. In some embodiments, there are provided methods and compositions for differentiating stem cells into pancreatic beta cells capable of producing insulin.[French]
L'invention concerne des procédés, des compositions et des kits appropriés pour une utilisation en thérapie cellulaire. Dans certains modes de réalisation, l'invention concerne des procédés et des compositions pour différencier des cellules souches en cellules bêta pancréatiques capables de produire de l'insuline.